News

C2 Therapeutics raises $11.6M for esophageal ablation

C2 Therapeutics raised $11.6 million from 44 investors to help advance its Coldplay Focal Cryoballoon Ablation System to treat Barrett's esophagus.

Report warns of cyberattacks against medical devices to extort money

Medical device cyber security concerns were aroused when a baddie in the show Homeland hacked into the vice president's pacemaker and initiated a fatal heart attack. Now, a report by the European Cybercrime Centre warns of the real rise of similar "ransomware" attacks, although financial gain, not murder, would be the goal.

Medtronic reveals corporate shakeup pending close of Covidien deal

Days after Medtronic revealed plans to refinance its $42.9 billion acquisition of Covidien due to new tax rules cracking down on inversions, the company announced a corporate shakeup pending the deal's close.

Researchers implant brain-controlled prosthetic arm with sensation

A robotic prosthetic controlled by implanted neuromuscular interfaces has been demonstrated to be clinically successful in a patient for the first time. The researchers expect to treat more patients with novel technology this year. The results are reported in the latest issue of Science Translational Medicine.

Khosla goes all in on consumer health wearables and med tech, leading $13M for Thync

Vinod Khosla has shown almost boundless enthusiasm for wearables and med tech. The latest of his investments in this segment came with the recent disclosure of a $13 million investment led by Khosla Ventures in wearable neuromodulator mood company Thync.

Stealth surgical reconstruction startup Tela-Bio raises $45.4M

Tela Bio, a Pennsylvania-based surgical reconstruction startup in stealth mode, raised $45.4 million from 29 investors, according to an SEC filing.

Hillary Clinton hedges on the device tax, says nation must weigh pros and cons

In a speech emphasizing the importance of compromise, likely presidential candidate Hillary Clinton said that there may be room for that dirty word in Washington when it comes to repealing the 2.3% medical device tax. That is a key demand of Republicans, not to mention of the device industry.

Boston Scientific wins positive recommendation from FDA panel for stroke-fighting Watchman device

Boston Scientific won a positive recommendation from an FDA panel for its stroke-fighting Watchman device, even as panel members expressed doubt that the product would work well in patients who are eligible for traditional drug therapy.

CoheroHealth to pilot asthma inhaler sensor and app at Mount Sinai Medical Center

Startup CoheroHealth, developer of the AsthmaHero app and spirometer for measuring the volume of air inhaled and exhaled by the lungs, will test its solution on 50 patients at New York City's Mount Sinai Medical Center.

UPDATED: Histogenics files for IPO, as Autogenomics refiles again

Implantable tissue repair player Histogenics has filed for an initial public offering to raise up to $65 million. The financing is to fund an ongoing Phase III trial for its NeoCart, an implant to repair knee cartilage damage. Meanwhile, Molecular diagnostics company AutoGenomics is hoping the third time's the charm with its IPO filing for up to $60 million.

Stanford researcher creating a novel device to study pain

Academics hope to enhance a new mouse model created to better understand how pain is transmitted in the body. Ada Poon, an assistant professor of electrical engineering at Stanford University, is working as part of a team to build a wireless device that incorporates existing optogenetics research.

EU halts distribution of GI Dynamics obesity device

The European Union suspended shipments of EndoBarrier, an obesity device from GI Dynamics, for reasons undisclosed by the company. GI Dynamics said the situation is temporary and does not apply to product already in the hands of hospitals and distributors.

Becton plans on $9.1B bridge loan to finance deal with CareFusion

Becton Dickinson plans to finance its acquisition of CareFusion with a $9.1 billion bridge loan, joining the ranks of other med tech outfits which have recently turned to loans for pending M&A deals.

FDA Commissioner addresses approval times, global competitiveness at AdvaMed

FDA Commissioner Margaret Hamburg devoted a large part of her luncheon remarks at the annual AdvaMed MedTech Conference in Chicago to boosting the American device industry's global competitiveness.

At least $200M paid to docs by medical device industry

The federal Open Payments database launched by the U.S.Health and Human Services Dept. announced that the medical device industry paid doctors at least $200 million last year. The database is taking the heat, however, for being generally inaccurate, incomplete and difficult to navigate

Preview: Boston Scientific's Watchman goes before third FDA panel

The long slog toward approval for Boston Scientific's Watchman implant continues today when it goes before a FDA advisory panel for a third time.

Med tech deal value up 363% in first half, with megadeals still pending

A recent report by Evaluate MedTech released at the annual AdvaMed med tech conference in Chicago found that M&A deal value in the med tech sector grew by 363% year over year in the first half of 2014 to $30 billion.

Intel, GE and Cigna expand remote care program for heart failure patients

A pilot program to remotely monitor blood pressure and weight for congestive heart failure patients is being expanded. The program shows how patients and healthcare providers can work together via technology to reduce hospital readmission.

Researchers develop a test for newly identified heart and gut disease

History and science have joined forces. Canadian researchers have discovered and identified a heart and gut disease caused by a genetic mutation that can be traced back to the 12th century Vikings. 

NanoString teams up with Brigham and Women's Hospital for cancer Dx development

NanoString Technologies is teaming up with Brigham and Women's Hospital to study genomic biomarkers and develop diagnostic tests for cancer, furthering the company's plans for accelerated growth.